13 X is among the least developed countries recognized by the United Nations. Since the bird flu hasbeen spreading over the country over six months and the toll of death is astonishinglyincreasing. In order to import sufficient and affordable medicine to assuage the damage of thepandemic, X plans to negotiate with Taiwanese pharmacy company Y, and asks Y to apply for thecompulsory licensing on Patent M registered in Taiwan that embodies the medicine B for treatingthe aforesaid bird flu. According to the Taiwan Patent Act, which of the following statements isappropriate?
(A) Y is not entitled to request the compulsory licensing on Patent M since the bird flu is not thedisease defined in Article 90 of Taiwan Patent Act.
(B) Y is not entitled to request the compulsory licensing on Patent M since the provisions of thecompulsory licensing are designed to mainly facilitate the demand in the domestic market.
(C) Y is entitled to request the compulsory licensing on Patent M, provided that X could prove thatit has insufficient or no manufacturing capacities in the pharmaceutical.
(D) Y is not entitled to request the compulsory licensing on Patent M unless Y has made efforts toobtain authorization from the patentee concerned on reasonable commercial terms andconditions and such efforts have not been successful within a reasonable period of time.